Security key
45256X103
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 201,140,507
- Total 13F value
- $1,760,071,081
- Share change
- +22,187,582
- Put/Call ratio
- 46%
- SEC-reported price per share
- $8.76
- Number of holders
- 401
- Value change
- +$200,865,142
- Number of buys
- 197
- Number of sells
- 144
- Shares outstanding
- 1,150,491,181
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
401
Top holders
10
IBRX full security history
Ownership snapshot
Full 13F holder table
ImmunityBio, Inc. SEC filings
ImmunityBio, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Patrick Soon-Shiong
Disclosed value leader
Patrick Soon-Shiong
Comparable rows
0/15
Latest evidence
31 Mar 2026
3/4/5
13F
Highest disclosed value: $572,512,835
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Patrick Soon-Shiong has the largest disclosed position value at $572.51M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Patrick Soon-Shiong's linked filing trail.
Disclosed position value
Top 5
Patrick Soon-Shiong
$572.51M
CALIFORNIA CAPITAL EQUITY, LLC
$571.73M
Cambridge Equities, LP
$571.73M
MP 13 Ventures, LLC
$571.73M
Nant Capital, LLC
$571.73M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Patrick Soon-Shiong |
3/4/5
Founder, Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
|
—
mixed-class rows
|
$572,512,835
288,867,272 shares
mixed-class rows
|
— | 31 Mar 2026 |
| CALIFORNIA CAPITAL EQUITY, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$571,730,825
288,752,943 shares
|
— | 31 Mar 2026 |
| Cambridge Equities, LP |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$571,730,825
288,752,943 shares
|
— | 31 Mar 2026 |
| MP 13 Ventures, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$571,730,825
288,752,943 shares
|
— | 31 Mar 2026 |
| Nant Capital, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$571,730,825
288,752,943 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$202,077,217
26,346,443 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
401
Shares
201,140,507
Rows available
401
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
382
Q2 2026 holders
401
Holder diff
19
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|